187 related articles for article (PubMed ID: 18777001)
61. Hypertrophic obstructive cardiomyopathy: preoperative echocardiographic predictors of outcome after septal myectomy.
McCully RB; Nishimura RA; Bailey KR; Schaff HV; Danielson GK; Tajik AJ
J Am Coll Cardiol; 1996 May; 27(6):1491-6. PubMed ID: 8626964
[TBL] [Abstract][Full Text] [Related]
62. Successful percutaneous septal alcohol ablation after surgical myectomy.
Kulić M; Spuzić M; Tahirović E; Sehović S; Mujacić V; Zorman D; Velebit V
Bosn J Basic Med Sci; 2010 Aug; 10(3):218-22. PubMed ID: 20846128
[TBL] [Abstract][Full Text] [Related]
63. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
[TBL] [Abstract][Full Text] [Related]
64. Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients.
Maron BJ; Yacoub M; Dearani JA
Eur Heart J; 2011 May; 32(9):1055-8. PubMed ID: 21324934
[TBL] [Abstract][Full Text] [Related]
65. Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation.
Cho YH; Quintana E; Schaff HV; Nishimura RA; Dearani JA; Abel MD; Ommen S
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):909-15; discussion 915-6. PubMed ID: 24930617
[TBL] [Abstract][Full Text] [Related]
66. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Nielsen CD; Fernandes V; Spencer WH
Am Heart Hosp J; 2003; 1(1):83-90. PubMed ID: 15785181
[TBL] [Abstract][Full Text] [Related]
67. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
Kurita T; Tsuchikane E; Tanaka N; Suzuki T
Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
[TBL] [Abstract][Full Text] [Related]
68. Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: a midterm follow-up.
Veselka J; Procházková S; Bolomová-Homolová I; Duchonová R; Tesar D
Echocardiography; 2005 Feb; 22(2):105-9. PubMed ID: 15693775
[TBL] [Abstract][Full Text] [Related]
69. Surgical septal myectomy for hypertrophic cardiomyopathy in Greece: a single-center initial experience.
Efthimiadis GK; Pitsis A; Pagourelias ED; Kamperidis V; Kelpis T; Meditskou S; Hadjimiltiades S; Ninios V; Mezilis N; Maron BJ; Styliadis IH
Hellenic J Cardiol; 2014; 55(2):132-8. PubMed ID: 24681791
[TBL] [Abstract][Full Text] [Related]
70. Quantitative and qualitative changes in the resting electrocardiograph after percutaneous transluminal septal myocardial ablation for the treatment of symptomatic obstructive hypertrophic cardiomyopathy.
Thai WE; Antonis PR; Hope SA; Meredith IT
Heart Lung Circ; 2008 Oct; 17(5):364-9. PubMed ID: 18657474
[TBL] [Abstract][Full Text] [Related]
71. Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.
Cui H; Schaff HV; Nishimura RA; Geske JB; Dearani JA; Lahr BD; Ommen SR
J Am Coll Cardiol; 2019 Aug; 74(5):645-655. PubMed ID: 31370956
[TBL] [Abstract][Full Text] [Related]
72. Ablation of hypertrophic septum using radiofrequency energy: an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy?
Riedlbauchová L; Janoušek J; Veselka J
J Invasive Cardiol; 2013 Jun; 25(6):E128-32. PubMed ID: 23735367
[TBL] [Abstract][Full Text] [Related]
73. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.
Kuhn H; Gietzen FH; Leuner C; Schäfers M; Schober O; Strunk-Müller C; Obergassel L; Freick M; Gockel B; Lieder F; Raute-Kreinsen U
Z Kardiol; 2000; 89 Suppl 4():IV41-54. PubMed ID: 10810776
[TBL] [Abstract][Full Text] [Related]
74. Effect of septal ablation on regional diastolic dysfunction and diastolic asynchrony in patients with hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography.
Chen S; Duan F; Yuan J; Qiao S; Lv X; Hu F; Yang W; Zhang J; Yang Y
Echocardiography; 2013 May; 30(5):564-71. PubMed ID: 23305549
[TBL] [Abstract][Full Text] [Related]
75. Peak systolic longitudinal strain of the lateral left ventricular wall improves after septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography.
Faber L; Prinz C; Welge D; Hering D; Butz T; Oldenburg O; Bogunovic N; Horstkotte D
Int J Cardiovasc Imaging; 2011 Mar; 27(3):325-33. PubMed ID: 20694748
[TBL] [Abstract][Full Text] [Related]
76. Looking back on 15 years of ultrasound-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Vermaete I; Dujardin K; Stammen F
Acta Cardiol; 2020 Oct; 75(6):483-491. PubMed ID: 31204591
[No Abstract] [Full Text] [Related]
77. Magnetic resonance imaging of microvascular obstruction in hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
Amano Y; Kitamura M; Yamada F; Aita K; Takayama M; Tachi M; Kumita S
Acta Radiol; 2015 Nov; 56(11):1323-8. PubMed ID: 25414371
[TBL] [Abstract][Full Text] [Related]
78. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002).
Fernandes VL; Nagueh SF; Wang W; Roberts R; Spencer WH
Clin Cardiol; 2005 Mar; 28(3):124-30. PubMed ID: 15813618
[TBL] [Abstract][Full Text] [Related]
79. Combined transaortic and transapical approach to septal myectomy in patients with complex hypertrophic cardiomyopathy.
Hang D; Schaff HV; Ommen SR; Dearani JA; Nishimura RA
J Thorac Cardiovasc Surg; 2018 May; 155(5):2096-2102. PubMed ID: 29153286
[TBL] [Abstract][Full Text] [Related]
80. Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring.
Faber L; Ziemssen P; Seggewiss H
J Am Soc Echocardiogr; 2000 Dec; 13(12):1074-9. PubMed ID: 11119274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
